Literature DB >> 19282669

How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

Yohannes Mebratu1, Yohannes Tesfaigzi.   

Abstract

Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) are members of the mitogen-activated protein kinase super family that can mediate cell proliferation and apoptosis. The Ras-Raf-MEK-ERK signaling cascade controlling cell proliferation has been well studied but the mechanisms involved in ERK1/2-mediated cell death are largely unknown. This review focuses on recent papers that define ERK1/2 translocation to the nucleus and the proteins involved in the cytosolic retention of activated ERK1/2. Cytosolic retention of ERK1/2 denies access to the transcription factor substrates that are responsible for the mitogenic response. In addition, cytosolic ERK1/2, besides inhibiting survival and proliferative signals in the nucleus, potentiates the catalytic activity of some proapoptotic proteins such as DAP kinase in the cytoplasm. Studies that further define the function of cytosolic ERK1/2 and its cytosolic substrates that enhance cell death will be essential to harness this pathway for developing effective treatments for cancer and chronic inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282669      PMCID: PMC2728430          DOI: 10.4161/cc.8.8.8147

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  135 in total

1.  Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.

Authors:  C Rommel; B A Clarke; S Zimmermann; L Nuñez; R Rossman; K Reid; K Moelling; G D Yancopoulos; D J Glass
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

2.  PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase.

Authors:  E Formstecher; J W Ramos; M Fauquet; D A Calderwood; J C Hsieh; B Canton; X T Nguyen; J V Barnier; J Camonis; M H Ginsberg; H Chneiweiss
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

3.  ERK2 enters the nucleus by a carrier-independent mechanism.

Authors:  Angelique W Whitehurst; Julie L Wilsbacher; Youngjai You; Kate Luby-Phelps; Mary Shannon Moore; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1.

Authors:  Z Yao; I Flash; Z Raviv; Y Yung; Y Asscher; S Pleban; R Seger
Journal:  Oncogene       Date:  2001-11-15       Impact factor: 9.867

5.  ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53.

Authors:  Damu Tang; Dongcheng Wu; Atsushi Hirao; Jill M Lahti; Lieqi Liu; Brie Mazza; Vincent J Kidd; Tak W Mak; Alistair J Ingram
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

6.  Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

Authors:  A Bonni; A Brunet; A E West; S R Datta; M A Takasu; M E Greenberg
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

7.  Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice.

Authors:  G Pagès; S Guérin; D Grall; F Bonino; A Smith; F Anjuere; P Auberger; J Pouysségur
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

8.  Evidence for existence of a nuclear pore complex-mediated, cytosol-independent pathway of nuclear translocation of ERK MAP kinase in permeabilized cells.

Authors:  Y Matsubayashi; M Fukuda; E Nishida
Journal:  J Biol Chem       Date:  2001-09-06       Impact factor: 5.157

9.  MEK-1/2 inhibition reduces branching morphogenesis and causes mesenchymal cell apoptosis in fetal rat lungs.

Authors:  David E Kling; Hans K Lorenzo; Alexander M Trbovich; T Bernard Kinane; Patricia K Donahoe; Jay J Schnitzer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-03       Impact factor: 5.464

10.  Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1.

Authors:  A E Aplin; S A Stewart; R K Assoian; R L Juliano
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

View more
  332 in total

1.  The α-isoform of class II phosphoinositide 3-kinase is necessary for the activation of ERK but not Akt/PKB.

Authors:  Z G Cui; N Y Hong; H K Kang; D H Lee; Y K Lee; D B Park
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

Review 2.  Emerging roles of PDGF-D signaling pathway in tumor development and progression.

Authors:  Zhiwei Wang; Aamir Ahmad; Yiwei Li; Dejuan Kong; Asfar S Azmi; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-04-28

Review 3.  MAPK signaling in inflammation-associated cancer development.

Authors:  Pengyu Huang; Jiahuai Han; Lijian Hui
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

4.  {Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells.

Authors:  L Toll; L Jimenez; N Waleh; K Jozwiak; A Y-H Woo; R-P Xiao; M Bernier; I W Wainer
Journal:  J Pharmacol Exp Ther       Date:  2010-11-11       Impact factor: 4.030

Review 5.  S100P: a novel therapeutic target for cancer.

Authors:  Thiruvengadam Arumugam; Craig D Logsdon
Journal:  Amino Acids       Date:  2010-05-28       Impact factor: 3.520

6.  The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation.

Authors:  Pei H Cui; Nenad Petrovic; Michael Murray
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

7.  Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways.

Authors:  Liang Guo; Sandy Eldridge; Mike Furniss; Jodie Mussio; Myrtle Davis
Journal:  Curr Protoc Chem Biol       Date:  2015-09-01

8.  EspH Suppresses Erk by Spatial Segregation from CD81 Tetraspanin Microdomains.

Authors:  Rachana Pattani Ramachandran; Felipe Vences-Catalán; Dan Wiseman; Efrat Zlotkin-Rivkin; Eyal Shteyer; Naomi Melamed-Book; Ilan Rosenshine; Shoshana Levy; Benjamin Aroeti
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

9.  A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.

Authors:  Seyyed Mehdi Jafari; Hamid Reza Joshaghani; Mojtaba Panjehpour; Mahmoud Aghaei
Journal:  Cell Oncol (Dordr)       Date:  2017-12-07       Impact factor: 6.730

10.  Characterization of adipocyte stress response pathways during hibernation in thirteen-lined ground squirrels.

Authors:  Andrew N Rouble; Shannon N Tessier; Kenneth B Storey
Journal:  Mol Cell Biochem       Date:  2014-04-29       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.